# ADC-1013 First-in-Human Study

> **NCT02379741** · PHASE1 · COMPLETED · sponsor: **Alligator Bioscience AB** · enrollment: 24 (actual)

## Conditions studied

- Neoplasms
- Solid Tumors

## Interventions

- **BIOLOGICAL:** ADC-1013

## Key facts

- **NCT ID:** NCT02379741
- **Lead sponsor:** Alligator Bioscience AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-03-08
- **Final completion:** 2017-03-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379741, "ADC-1013 First-in-Human Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02379741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*